Fri, February 7, 2020

David Lebovitz Maintained (ALNY) at Buy with Decreased Target to $148 on, Feb 7th, 2020

David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $150 to $148 on, Feb 7th, 2020.

David has made no other calls on ALNY in the last 4 months.



There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $190 on, Thursday, December 19th, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $176 on, Wednesday, December 18th, 2019
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $143 on, Monday, November 25th, 2019
  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019